ALIMERA SCIENCES EUROPE LIMITED

Alimera Sciences Europe Ltd is a Dublin-based pharmaceutical company dedicated to developing innovative, vision-improving treatments for chronic retinal diseases. With a clear focus on retinal health, Alimera works to help patients maintain better sight for longer, aiming to reduce the frequency of treatments required.

The company's portfolio centres on cutting-edge therapies that address the underlying causes of retinal conditions, striving to make a tangible impact on patients' everyday lives. Alimera places a strong emphasis on collaboration, partnering with ophthalmologists, patient organisations and other stakeholders to ensure its solutions meet real-world needs.

By combining scientific expertise with a patient-first ethos, Alimera Sciences Europe Ltd positions itself as an invaluable partner to both the medical community and those living with retinal disease, championing longer-lasting vision across Ireland and the wider EMEA region.